MobileODT

MobileODT is an Israeli FemTech company founded in 2012, dedicated to improving cervical cancer screening and treatment through mobile health technology. The company has developed the EVA (Enhanced Visual Assessment) System, a digital mobile colposcope that connects to a smartphone. This system allows healthcare providers to capture high-quality cervical images for early cancer detection and is FDA-approved as a video colposcope. It is designed to be affordable, portable, and cloud-based, making it suitable for low-resource settings worldwide. MobileODT offers a comprehensive cervical cancer screening and treatment solution that combines advanced optical technology with smartphone capabilities and AI software. The AI component delivers diagnostic results within 60 seconds, achieving accuracy comparable to expert colposcopists. The technology is utilized in over 60 countries, with more than 5,000 users, and has facilitated the capture of over 1 million cervical images. MobileODT's solutions are employed by prominent healthcare organizations in the U.S. and play a vital role in national screening programs globally, contributing to early detection and improved treatment outcomes.

• Employees 10
• Founded 2017
• Annual Revenue $7400000
• Total Funding $21480000